Runx1 Research Program

Improve the quality of life and prevent cancer in patients with germline mutations.

Based in CA

Share:𝕏LinkedInFacebook
🤖

AI Overview

With $80K in lobbying spend across 5 quarterly filings, Runx1 Research Program is an active lobbying client. Their lobbying covers 1 issue area.

$80K
Total Spend
1
Years Active
1
Firms Hired
1
Lobbyists Deployed
1
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2021$80K

Issues Lobbied

Budget/Appropriations

Lobbying Firms

Cornerstone Government Affairs, INC.

Lobbyists

Erik Fatemi

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Budget/Appropriations

  • •Seeking additional funding for research on RUNX1 germline mutations at the National Institutes of Health.
  • •Budget issues
  • •Appropriations for research on germline RUNX1 mutations

Related Analysis

📈 Client Trajectories
See how this client compares to others over time
🎯 Market Concentration
How concentrated is the lobbying market?
🚀 Spending Momentum
Which issues are surging right now?

Related Investigations

The 22,000% ROI
When lobbying spending yields outsized returns.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.

Similar Clients

Kaiser Foundation Health Plan INC
$31.5M total spend
Biomarin Pharmaceutical INC.
$9.6M total spend
Sony Pictures Entertainment INC.
$8.6M total spend
Gap INC.
$8.3M total spend
Acadia Pharmaceuticals
$7.3M total spend

Explore More

← All Clients⚖️ Compare Clients💵 ROI Calculator🔍 Investigations📖 How Lobbying Works🕸️ Network Analysis🏛️ Agency Pressure

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.